Literature DB >> 15153762

Present status of renal cell carcinoma in dialysis patients in Japan: questionnaire study in 2002.

Isao Ishikawa1.   

Abstract

AIMS: To determine the incidence and recent trends of renal cell carcinoma (RCC) in dialysis patients, a nationwide investigation was performed in Japan.
METHODS: In February 2002, 3,155 questionnaires were sent to dialysis units in Japan. The variables studied for RCC diagnosed between March 2000 and February 2002 included patient age, duration of dialysis, diagnostic aids, cancer size, histology of cancer, and the presence of metastasis and acquired cysts.
RESULTS: 489 RCCs (381 males, 104 females, and 4 unknown) were studied. The mean age of the RCC patients was 57.5 +/- 11.4 (mean +/- SD) years, and the mean duration of dialysis was 136.9 +/- 95.2 months. RCC was detected by symptoms alone in 5.3% of the cases, by sonographic screening in 46.1%, and computed tomographic screening in 44.2%. The metastasis rate was 15.2%. The standardized incidence ratio was 9.7 (95% confidence interval, CI: 8.3-11.2) for the male dialysis patients and 11.0 (95% CI: 8.2-14.4) for the female patients. Eighty-four of the RCC patients with more than 20 years of hemodialysis were younger, were more frequently male, and demonstrated a larger cancer size, a higher incidence of papillary RCC, a higher metastasis rate, and a higher incidence of fatal RCC than 215 patients with less than 10 years of dialysis.
CONCLUSION: 54.6% of the patients with RCC received dialysis for more than 10 years. For RCC patients with more than 20 years of dialysis, the mean age was younger, and the metastasis rate was higher than for RCC patients with less than 10 years of dialysis. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2004        PMID: 15153762     DOI: 10.1159/000077590

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  7 in total

1.  Genomic profiling of renal cell carcinoma in patients with end-stage renal disease.

Authors:  Toru Inoue; Keiko Matsuura; Taichiro Yoshimoto; Lam Tung Nguyen; Yoshiyuki Tsukamoto; Chisato Nakada; Naoki Hijiya; Takahiro Narimatsu; Takeo Nomura; Fuminori Sato; Yoji Nagashima; Kenji Kashima; Shingo Hatakeyama; Chikara Ohyama; Kazuyuki Numakura; Tomonori Habuchi; Masayuki Nakagawa; Masao Seto; Hiromitsu Mimata; Masatsugu Moriyama
Journal:  Cancer Sci       Date:  2012-01-20       Impact factor: 6.716

2.  Renal cell carcinoma arising from a horseshoe kidney in a chronic hemodialysis patient.

Authors:  Yasumasa Miyazaki; Akira Miyajima; Takahiro Maeda; Yujiro Ito; Nobuyuki Tanaka; Takeo Kosaka; Aya Masuda; Ryuichi Mizuno; Eiji Kikuchi; Ken Nakagawa; Mototsugu Oya
Journal:  Clin Exp Nephrol       Date:  2012-06-28       Impact factor: 2.801

3.  Outcome of advanced renal cell carcinoma arising in end-stage renal disease: comparison with sporadic renal cell carcinoma.

Authors:  Hiroki Ishihara; Hironori Fukuda; Hidekazu Tachibana; Kazuhiko Yoshida; Hirohito Kobayashi; Toshio Takagi; Junpei Iizuka; Hideki Ishida; Yoji Nagashima; Tsunenori Kondo; Kazunari Tanabe
Journal:  Clin Exp Nephrol       Date:  2021-02-27       Impact factor: 2.801

4.  Imaging of acquired cystic disease-associated renal cell carcinoma by contrast-enhanced ultrasonography with perflubutane microbubbles and positron emission tomography-computed tomography.

Authors:  Isao Ishikawa; Kyoko Morita; Satoshi Hayama; Tetsuya Nakazawa; Ichiro Araki; Kotaro Higashi; Katsuhito Miyazawa; Koji Suzuki; Takayuki Nojima
Journal:  Clin Exp Nephrol       Date:  2010-09-09       Impact factor: 2.801

5.  Comparison of prognosis between patients with renal cell carcinoma on hemodialysis and those with renal cell carcinoma in the general population.

Authors:  Yasunobu Hashimoto; Toshio Takagi; Tsunenori Kondo; Junpei Iizuka; Hirohito Kobayashi; Kenji Omae; Kazuhiko Yoshida; Kazunari Tanabe
Journal:  Int J Clin Oncol       Date:  2015-03-12       Impact factor: 3.402

6.  [Malignant neoplasms and kidney transplantation].

Authors:  H Heynemann; A Hamza; S Wagner; R Hoda; A Schumann; P Fornara
Journal:  Urologe A       Date:  2009-12       Impact factor: 0.639

Review 7.  Renal Cell Carcinoma in End-Stage Renal Disease: A Review and Update.

Authors:  Ziad M El-Zaatari; Luan D Truong
Journal:  Biomedicines       Date:  2022-03-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.